SLNO

Soleno Therapeutics
SLNO

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$3.99B
EV
$3.75B
Shares Outstanding
53.94M
Beta
-2.67

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$111.00
P/E 2025E
-
P/Revenue 2025E
85.04x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Soleno Therapeutics, Inc.

gainify
SLNO

Soleno Therapeutics, Inc.

SLNO

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet...

Sector

Healthcare

Industry

Biotechnology

CEO

Bhatnagar, Anish

Employees

115

IPO Date

2014-11-13

Headquarters

203 Redwood Shores Parkway, Suite 500, Redwood City, California, 94065, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.